Cytotoxic Activity and Senescence Modulatory Effect of Hesperetin on Triple-Negative Breast Cancer Cells and Kidney Cells Co-Treatment with Cisplatin
Abstract
Cisplatin (Cisp) is a non-specific chemotherapeutic agent for breast cancer. Hesperetin (HST), a flavanone found in various citrus fruits, exhibits bioactive properties, functioning as an antioxidant, anti-inflammatory, and anticancer agent. The objective of this research was to investigate the potential of HST as a co-chemotherapeutic agent in conjunction with Cisp, specifically focusing on its cytotoxic effects against 4T1 triple-negative breast cancer cells and senescence modulatory effect on Vero normal kidney cells. The cytotoxic effect and viability cell of HST were evaluated through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay. In addition, the effect of cellular senescence inhibition on the Vero cell line was measured using senescence-associated β-galactosidase (SA-β-gal) staining. In the MTT assay, both HST and cisplatin demonstrated a reduction in the viability of 4T1 cells in a dose-dependent manner, yielding IC50 values of 498 μM and 2 μM, respectively. The co-treatment of HST and cisplatin showed an increase in sensitivity of the 4T1 cells with a combination index of <1. HST showed low cytotoxic activity against Vero cells, with IC50 values of over 500 μM. HST decreased cellular senescence induced by cisplatin exposure on Vero cells. These results indicated that HST in co-treatment with cisplatin decreased 4T1 cell viability synergistically. HST independently reduces the cellular senescence of normal cells. Consequently, HST holds promise for potential development as a co-treatment agent in combination with cisplatin for breast cancer cells, and it may also serve as an alternative for counteracting senescence in healthy tissues.
Keywords: cytotoxic, senescence, hesperetin, cisplatin, breast cancer.
Full Text:
PDFReferences
Aljewari, H., AL-Faisal, A.H.M. and Nader, M., 2010, In vitro Cytotoxic Activity of the L-asparaginase Extracted and Purifed from Pathogenic Escherichia coli Against four Leukemic cell lines. Presented at the 2nd Annual International Conference of Northest Pharmacy Research, Faculty of Pharmacy, Mahasarkham University, Thailand, pp. 21–23. Link
Cao, H., Phan, H., and Yang, L.X., 2012, Improved chemotherapy for hepatocellular carcinoma, Anticancer Res., 32(4), 1379–1386. Link
Du, G., Lin, H., Wang, M., Zhang, S., Wu, X., Lu, L., et al., 2010, Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells, Cancer Chemotherapy and Pharmacology, 65(2), 277–287. CrossRef
Khan, A., Ikram, M., Hahm, J.R., and Kim, M.O., 2020, Antioxidant and anti-inflammatory effects of citrus flavonoid hesperetin: Special focus on neurological disorders, Antioxidants, 9(7), 609. CrossRef
Kleih, M., Böpple, K., Dong, M., Gaißler, A., Heine, S., Olayioye, M.A., et al., 2019, Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells, Cell Death & Disease, 10(11), 851. CrossRef
Li, C., Xie, N., Li, Y., Liu, C., Hou, F.F., and Wang, J., 2019, N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation, Free Radical Biology and Medicine, 130, 512–527. CrossRef
Meiyanto, E., Putri, H., Larasati, Y.A., Utomo, R.Y., Jenie, R.I., Ikawati, M., et al., 2019, Antiproliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation, Adv Pharm Bull., 9(3), 445–452. CrossRef
Mohamad, N.E., Abu, N., Yeap, S.K., and Alitheen, N.B., 2019, Bromelain enhances the anti-tumor effects of cisplatin on 4T1 breast tumor model in vivo, Integrative Cancer Therapies, 18, 1534735419880258. CrossRef
Myrianthopoulos, V., Evangelou, K., Vasileiou, P.V.S., Cooks, T., Vassilakopoulos, T.P., Pangalis, G.A., et al., 2019, Senescence and senotherapeutics: a new field in cancer therapy, Pharmacology & Therapeutics, 193, 31–49. CrossRef
Nurhayati, I.P., Khumaira, A., Ilmawati, G.P.N., Meiyanto, E., and Hermawan, A., 2020, Cytotoxic and antimetastatic activity of hesperetin and doxorubicin combination toward Her2 expressing breast cancer cells, Asian Pacific Journal of Cancer Prevention: APJCP, 21(5), 1259. CrossRef
Pan, H., Chen, J., Shen, K., Wang, X., Wang, P., Fu, G., et al., 2015, Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice, PloS One, 10(4), e0124775. CrossRef
Prayong, P., Barusrux, S., and Weerapreeyakul, N., 2008, Cytotoxic activity screening of some indigenous Thai plants, Fitoterapia, 79(7–8), 598–601. CrossRef
Qu, K., Lin, T., Wei, J., Meng, F., Wang, Z., Huang, Z., et al., 2013, Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells, Nan Fang Yi Ke Da Xue Xue Bao, 33(9), 1253–1259. CrossRef
Rahideh, S.T., Keramatipour, M., Nourbakhsh, M., Koohdani, F., Hoseini, M., and Shidfar, F., 2017, The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells, Cellular and Molecular Biology, 63(2), 9–13. CrossRef
Sarmoko, Putri, D.D.P., Susidarti, R.A., Nugroho, A.E., and Meiyanto, E., 2014, Increasing Sensitivity of MCF-7/Dox Cells Towards Doxorubicin By Hesperetin Through Suppression of P-Glycoprotein Expression, Indonesian Journal of Pharmacy, 25(2), 84-90.
Sutejo, I.R., Putri, H., and Meiyanto, E., 2016, The Selectivity of Ethanolic Extract of Buah Makassar (Brucea javanica) on Metastatic BreastCancer Cells, J. Agromedicine Med. Sci., 2, 1–6. CrossRef
Yap, K.M., Sekar, M., Wu, Y.S., Gan, S.H., Rani, N.N.I.M., Seow, L.J., et al., 2021, Hesperidin and its aglycone hesperetin in breast cancer herapy: A review of recent developments and future prospects, Saudi Journal of Biological Sciences, 28(12), 6730–6747. CrossRef
Yu, W., Chen, Y., Dubrulle, J., Stossi, F., Putluri, V., Sreekumar, A., et al., 2018, Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism, Scientific Reports, 8(1), 4306. CrossRef
Yunita, E., Muflikhasari, H.A., Ilmawati, G.P.N., Meiyanto, E., and Hermawan, A., 2020, Hesperetin alleviates doxorubicin-induced
migration in 4T1 breast cancer cells, Future Journal of Pharmaceutical Sciences, 6(1), 1–9. CrossRef
Zwelling, L.A., Michaels, S., Schwartz, H., Dobson, P.P., and Kohn, K.W., 1981, DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard, Cancer Res., 41, 640–649. Link
Zhang, A., Sun, H., and Wang, X., 2013, Recent advances in natural products from plants for treatment of liver diseases, European Journal of Medicinal Chemistry, 63, 570–577. CrossRef
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev14iss3pp181-188
Copyright (c) 2023 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
